Product
Cerezyme
Aliases
Cerezyme® / Imiglucerase
1 clinical trial
1 indication
Indication
Gaucher DiseaseClinical trial
A Single Arm, Prospective, Open Label, Multicenter Study to Evaluate Efficacy and Safety of One-year Maximum Dosage in Chinese Label of Imiglucerase Treatment in Chinese Patients Who Are Diagnosed as Gaucher Disease Type ⅢStatus: Completed, Estimated PCD: 2023-10-12